Cargando…
SR-17018 Stimulates Atypical µ-Opioid Receptor Phosphorylation and Dephosphorylation
Opioid-associated overdoses and deaths due to respiratory depression are a major public health problem in the US and other Western countries. In the past decade, much research effort has been directed towards the development of G-protein-biased µ-opioid receptor (MOP) agonists as a possible means to...
Autores principales: | Fritzwanker, Sebastian, Schulz, Stefan, Kliewer, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348759/ https://www.ncbi.nlm.nih.gov/pubmed/34361663 http://dx.doi.org/10.3390/molecules26154509 |
Ejemplares similares
-
Molecular Modeling of µ Opioid Receptor Ligands with Various Functional Properties: PZM21, SR-17018, Morphine, and Fentanyl—Simulated Interaction Patterns Confronted with Experimental Data
por: Podlewska, Sabina, et al.
Publicado: (2020) -
HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants
por: Fritzwanker, Sebastian, et al.
Publicado: (2021) -
In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies
por: Fritzwanker, Sebastian, et al.
Publicado: (2023) -
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
por: Kliewer, A., et al.
Publicado: (2019) -
Carboxyl-Terminal Receptor Domains Control the Differential Dephosphorylation of Somatostatin Receptors by Protein Phosphatase 1 Isoforms
por: Lehmann, Andreas, et al.
Publicado: (2014)